Journals / Veteriner Bilimleri Dergisi . Eurasian Journal of Veterinary Sciences / 2004 / Cilt: 20 - Sayı: 2

Are fixed oils of Urtica pilulifera L. protective against carboplatin-induced hepatotoxicity

Urtica pilulifera L. sabit yağı karboplatine'e bağlı hepatotoksisiteye karşı koruyucu mu

Pages
53–58
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Fixed oils of Urtica pilulifera L. appears to be equally effective like vitamin C and vitamin E in alleviating carboplatin-induced hepatotoxicity.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:In this study effects of Urtica pilulifera L. extracts against carboplatin-induced hepatotoxicity were investigated in rats.
📊
Key Findings & Data:The fixed oils of Urtica pilulifera L. group displayed significantly lower alanine aminotransferase, alkaline phosphatase and indirect bilirubin levels compared to the carboplatin group.
💡
Conclusion & Impact:Fixed oils of Urtica pilulifera L. appears to be equally effective like vitamin C and vitamin E in alleviating carboplatin-induced hepatotoxicity.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:bitki özütü · insan · Urtica

Abstract

In this study effects of Urtica pilulifera L. extracts against carboplatin-induced hepatotoxicity were investigated in rats. Sprague-Dawley rats were divided into five study groups and given isotonic saline solution, carboplatin, carboplatin+fixed oil of Urtica pilulifera L., carboplatin+vitamin C and carboplatin+vitamin E respectively. In histological examination of liver sections none of the groups exhibited pathological changes. The liver injury is evidenced by rise of serum alanine aminotransferase, alkaline phosphatase and indirect bilirubin levels in carboplatin group compared to the controls. The fixed oils of Urtica pilulifera L. group displayed significantly lower alanine aminotransferase, alkaline phosphatase and indirect bilirubin levels compared to the carboplatin group. Vitamin C and E displayed similar biochemical changes as fixed oils of Urtica pilulifera L. Fixed oils of Urtica pilulifera L. appears to be equally effective like vitamin C and vitamin E in alleviating carboplatin-induced hepatotoxicity.

Özet

Bu çalışmada karboplatinin sıçan karaciğerinde yaptığı toksisite üzerine Urtica pilulifera L. sabit yağının koruyucu etkisi araştırıldı. Sprague-Dawley ırkı sıçanlardan oluşturulan beş çalışma grubuna, sırayla serum fizyolojik (kontrol), karboplatin, kar-boplatin+ Urtica pilulifera L. (ısırgan otu) sabit yağı, karboplatin+vitamin C ve karboplatin+vitamin E uygulandı. Çalışma gruplarında karaciğerlere ait histopatolojik bulguya rastlanmadı. Serum alanin aminotransferaz, alkalen fosfataz ve indirekt bilirubin seviyeleri karboplatin grubunda kontrol grubuna göre anlamlı derecede yüksekti ve karboplatinin biyokimyasal enzimler düzeyinde karaciğer hasarı yaptığı şeklinde yorumlandı. Isırgan otu sabit yağının alanin aminotransferaz, alkalen fosfataz ve indirekt bilirubin düzeyleri karboplatin grubundan anlamlı derecede düşüktü. Isırgan otu sabit yağı ile kontrol grubu arasında anlamlı farklılık saptanmadı. Vitamin C ve vitamin E uygulanan gruplarda belirlenen biyokimyasal değerler ise ısırgan otu sabit yağına benzer şekilde bulundu. Isırgan otu sabit yağı uygulamasının karboplatine bağlı karaciğer toksisitesini vitamin C ve E'ye eşit sayılabilecek derecede önleyebileceği sonucuna varıldı.

🔖

Cite This Article

ÖZBEK, H., KÖSEM, M., ERDOĞAN, E., CENGİZ, N., ÖZGÖKÇE, F., SEVER, B. (2004). Are fixed oils of Urtica pilulifera L. protective against carboplatin-induced hepatotoxicity. Veteriner Bilimleri Dergisi . Eurasian Journal of Veterinary Sciences, Cilt: 20 - Sayı: 2, 53–58. https://ajindex.com/articles/333506

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Akbay, P., Başaran, AA, Undeger, U., Başaran, N. (2003). In Vitro Immunomodulatory Activity of Flavonoid Glycosides from Urtica dioica L. Phytother. Res. 17(1), 34-37.
  2. Bacha, D.M., Caparros-Sison, B., Allen, J.A., Walker, R., Tan, C.T. (1986). Phase I Study of Carboplatin (CBDCA) in Children with Cancer. Cancer Treat. Rep. 70(7), 865-869.
  3. Baytop, T. (1999). Bitkilerle Tedavi. 2. baskı, İstanbul:
  4. Nobel Tıp Kitabevleri, İstanbul Türkiye. Bnouham, M., Merhfour, F.Z., Ziyyat, A., Mekhfi, H., Aziz, M., Legssyer, A. (2003). Antihyperglycemic Activity of The Aqueous Extract of Urtica dioica. Fitoterapia 74(7-8), 677-681.
  5. Carles, J., Nogue, M., Domenech, M., Perez, C., Saigi, E., Villadiego, K., et al. (2000). Carboplatin-Gemcitabine Treatment of Patients with Transitional Cell Carcinoma of The Bladder and Impaired Renal Function. Oncology 59(1), 24-27.
  6. Chang, A.Y., Hui, L, Asbury, R., Boros, L., Garrow, G., Rubins, J. (1999).
  7. Ifosfamide, Carboplatin and Etoposide (ICE) in Metastatic and Refractory Breast Cancer. Cancer Chemother. Pharmacol. 44 Suppl, 26-28.
  8. Chu, G., Mantin, R., Shen, Y.M., Baskett, G., Sussman, H. (1993). Massive Cisplatin Overdose by Accidental Substitution for Carboplatin. Toxicity and management. Cancer 72(12), 3707-3714.
  9. Drisko, J.A., Chapman, J., Hunter, V.J. (2003). The use of antioxidants with first-line chemotherapy in two cases of ovarian cancer. J. Am. Coll. Nutr. 22(2), 118-123.
  10. Dvorkin, L., Song, K.Y. (2002). Herbs for Benign Prostatic Hyperplasia. Ann. Pharmacother. 36(9), 1443-1452.
  11. Ettinger, L.J., Ivy, P., Gaynon, P.S., Ettinger, A.G., Liu-Mares, W„ Krailo, M.D. (1986). A Phase II Study of Carboplatin as A Treatment for Children with Acute Leukemia Recurring in Bone Marrow: A Report of The Children's Cancer Group. Cancer 80(2), 311 -316. Ettinger, L.J., Krailo, M.D., Gaynon, P.S., Hammond, G.D. (1993). A Phase I Study of Carboplatin in Cchildren with Acute Leukemia in Bone Marrow Relapse. A Report From the Childrens Cancer Group. Cancer 72(3), 917-922.
  12. Ghalie, R„ Williams, S.F., Valentino, L.A., Feingold, J., Korenblit, A.D., Adler, S.S. (1995). Tandem Peripheral Blood Progenitor Cell Transplants as Initial Therapy for Metastatic Breast Cancer. Biol. Blood Marrow Transplant. 1(1), 40-46.
  13. Hardman, G.J., Limbird Lee, E., Molinoff, P.B., Ruddon, R.W., Gilman, A.G. (1996). Goodman Gilman's The Pharmacological Basis of Therapeutics. In: Edited by Chabner BA, Allegra CJ, Curt GA et al. Antineoplastic agents. 9th ed. International edition